{"id":"https://openalex.org/W7169853280","doi":"https://doi.org/10.1158/1557-3265.d32026-b086","title":"Abstract B086: Aspartyl/asparaginyl beta-hydroxylase (ASPH) blockade abrogates doxorubicin induced chemoresistance in chondrosarcoma","display_name":"Abstract B086: Aspartyl/asparaginyl beta-hydroxylase (ASPH) blockade abrogates doxorubicin induced chemoresistance in chondrosarcoma","publication_year":2026,"publication_date":"2026-07-21","ids":{"openalex":"https://openalex.org/W7169853280","doi":"https://doi.org/10.1158/1557-3265.d32026-b086"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.d32026-b086","doi":"https://doi.org/10.1158/1557-3265.d32026-b086","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.d32026-b086","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5141289234","display_name":"Keisuke Oyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keisuke Oyama","raw_affiliation_strings":["1Brown University, Providence, RI,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Brown University, Providence, RI,","institution_ids":["https://openalex.org/I27804330"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001420554","display_name":"Max Petersen","orcid":"https://orcid.org/0000-0003-3179-4619","observed_orcids":["https://orcid.org/0000-0003-3179-4619"]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Max Petersen","raw_affiliation_strings":["1Brown University, Providence, RI,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Brown University, Providence, RI,","institution_ids":["https://openalex.org/I27804330"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5141311697","display_name":"Adinai Chonweerawong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adinai Chonweerawong","raw_affiliation_strings":["1Brown University, Providence, RI,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Brown University, Providence, RI,","institution_ids":["https://openalex.org/I27804330"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017203868","display_name":"Mark Jon Olsen","orcid":"https://orcid.org/0000-0003-2871-1923","observed_orcids":["https://orcid.org/0000-0003-2871-1923"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Olsen","raw_affiliation_strings":["2Midwestern University, Phoenix, AZ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Midwestern University, Phoenix, AZ","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086701763","display_name":"Richard M. Terek","orcid":"https://orcid.org/0000-0002-6322-6790","observed_orcids":["https://orcid.org/0000-0002-6322-6790"]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Terek","raw_affiliation_strings":["1Brown University, Providence, RI,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Brown University, Providence, RI,","institution_ids":["https://openalex.org/I27804330"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"14_Supplement","first_page":"B086","last_page":"B086"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10975","display_name":"Bone Tumor Diagnosis and Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10975","display_name":"Bone Tumor Diagnosis and Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chondrosarcoma","display_name":"chondrosarcoma","score":0.9440000057220459},{"id":"https://openalex.org/keywords/aspartyl-asparaginyl-beta-hydroxylase","display_name":"aspartyl/asparaginyl beta-hydroxylase","score":0.9459999799728394},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8970000147819519},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.9700000286102295},{"id":"https://openalex.org/keywords/notch1-signaling","display_name":"Notch1 signaling","score":0.8460000157356262},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6399999856948853},{"id":"https://openalex.org/keywords/mrp1","display_name":"MRP1","score":0.8640000224113464},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.5519999861717224},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5249999761581421},{"id":"https://openalex.org/keywords/crispr-cas9-knockout","display_name":"CRISPR/Cas9 knockout","score":0.7670000195503235},{"id":"https://openalex.org/keywords/chondrocytes","display_name":"chondrocytes","score":0.8270000219345093},{"id":"https://openalex.org/keywords/oncofetal-protein","display_name":"oncofetal protein","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.8245000243186951},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.7159000039100647},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7056999802589417},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6621999740600586},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.59170001745224},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.5019999742507935},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.39640000462532043},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.37389999628067017},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.37119999527931213},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.3325999975204468},{"id":"https://openalex.org/C2776302905","wikidata":"https://www.wikidata.org/wiki/Q1076087","display_name":"Chondrosarcoma","level":2,"score":0.3075999915599823},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28679999709129333},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.27309998869895935},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.25459998846054077},{"id":"https://openalex.org/C161879069","wikidata":"https://www.wikidata.org/wiki/Q904082","display_name":"Notch signaling pathway","level":3,"score":0.25440001487731934}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.d32026-b086","doi":"https://doi.org/10.1158/1557-3265.d32026-b086","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.d32026-b086","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7169823339","https://openalex.org/W4410409705","https://openalex.org/W2474355394","https://openalex.org/W2170878678","https://openalex.org/W2999111930","https://openalex.org/W4408375215","https://openalex.org/W7222453602","https://openalex.org/W2890262061","https://openalex.org/W4313584809","https://openalex.org/W4405807446"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Chondrosarcoma":[2],"(CS)":[3],"is":[4,31,38,52,401],"notable":[5],"for":[6,88,183],"being":[7],"resistant":[8],"to":[9,14,70,83,91,197,200,245,250,394,403,425,428,438],"cytotoxic":[10,423],"chemotherapy,":[11],"which":[12,51],"contributes":[13],"poor":[15],"survival.":[16,46],"Molecular":[17],"mechanisms":[18],"underpinning":[19],"CS":[20,68,100,186,214,230,263,289,328],"chemoresistance":[21,463],"and":[22,86,90,98,102,113,138,147,156,167,192,220,238,247,269,272,286,301,316,325,338,350,361,367,375,432,473],"methods":[23],"of":[24,57,79,282,345,358,372,417,469],"reversal":[25],"are":[26],"incomplete.":[27],"Aspartyl/asparaginyl":[28,456],"beta-hydroxylase":[29,457],"(ASPH)":[30,458],"an":[32],"oncofetal":[33],"cell":[34,329],"surface":[35],"protein":[36,280],"that":[37,63],"overexpressed":[39],"in":[40,54,195,213,218,229,257,288,297,307,342,385,420,464],"CS;":[41],"high":[42],"expression":[43,151,191,306,344,357,371,400],"predicts":[44],"worse":[45],"ASPH":[47,64,107,190,232,237,305,308,323,337,399,418,440],"augments":[48],"Notch":[49,145,339,377],"signaling,":[50],"implicated":[53],"the":[55],"hallmarks":[56],"cancer,":[58],"including":[59],"chemoresistance.":[60],"We":[61],"hypothesized":[62],"inhibitor":[65],"MO-I-1182":[66,85,122,198,206,296,363],"sensitizes":[67],"cells":[69,101,187,215],"doxorubicin":[71,461],"(dox),":[72],"a":[73,258,298,334,382,408,429],"standard":[74],"sarcoma":[75],"chemotherapeutic.":[76],"The":[77],"purpose":[78],"this":[80,365,433],"study":[81],"was":[82,109,133,223],"evaluate":[84],"dox":[87,125,208,211,255,265,326,355,369],"synergy,":[89],"determine":[92],"underlying":[93],"molecular":[94],"mechanisms.":[95],"Methods:":[96],"CS-1":[97],"JJ012":[99],"C28/I2":[103],"chondrocytes":[104],"were":[105,119,152,161,175,274,293,302],"used.":[106],"knockout":[108],"performed":[110],"with":[111,116,121,135,154,170,177,205,422],"CRISPR/Cas9":[112],"Notch1":[114,234,239,252],"knockdown":[115,235,253],"siRNA.":[117],"Cells":[118],"treated":[120],"(0-100":[123],"uM),":[124,127],"(0-1":[126],"or":[128,233],"both":[129],"drugs.":[130],"Cell":[131],"viability":[132,194],"measured":[134],"MTT":[136],"assay":[137],"nuclear":[139],"staining":[140],"(Hoechst":[141],"33342).":[142],"ASPH,":[143,267,283,359,373],"Notch,":[144,360,374],"effectors,":[146],"drug":[148,346],"transporter":[149,348],"ABCC1":[150,270,287],"analyzed":[153,169],"qRT-PCR":[155],"Western":[157],"blot.":[158],"Dose-response":[159],"curves":[160],"compared":[162,199],"using":[163],"nonlinear":[164],"mixed":[165],"models,":[166],"synergy":[168,321],"Compusyn":[171],"software.":[172],"Other":[173],"comparisons":[174],"made":[176],"Student\u2019s":[178],"t-test,":[179],"p":[180],"\u2264":[181],"0.05":[182],"significance.":[184],"Results:":[185],"showed":[188,209],"higher":[189],"decreased":[193,243],"response":[196],"normal":[201],"chondrocytes.":[202],"Combination":[203],"treatment":[204,222],"plus":[207],"reduced":[210,236],"EC50":[212],"but":[216,388],"not":[217],"chondrocytes,":[219],"combination":[221,421],"synergistic":[224],"at":[225],"all":[226,273],"doses":[227],"tested":[228],"cells.":[231,290,310],"target":[240,396],"gene":[241],"expression,":[242],"sensitivity":[244,249,256],"MO-I-1182,":[246],"increased":[248,254,266,279,343],"dox.":[251],"dose":[259],"dependent":[260,303],"manner.":[261],"In":[262],"cells,":[264,405],"Notch1,":[268,285],"transcripts,":[271],"mitigated":[275],"by":[276,295,319,354],"MO-I-1182.":[277],"Dox":[278],"levels":[281],"activated":[284],"These":[291],"increases":[292],"blocked":[294],"dose-responsive":[299],"manner,":[300],"on":[304,327,356],"KO":[309],"Conclusions:":[311],"Our":[312,413],"findings":[313,414],"show":[314],"conceptual":[315],"pre-clinical":[317],"innovation":[318],"identifying":[320],"between":[322,336],"inhibition":[324,379,419],"viability.":[330],"Mechanistically,":[331],"we":[332],"observed":[333],"link":[335],"signaling":[340,378],"resulting":[341],"efflux":[347],"ABCC1,":[349],"positive":[351],"feedback":[352],"induced":[353,370,462],"ABCC1.":[362,376],"inhibits":[364],"pathway":[366],"counteracts":[368],"has":[380],"been":[381],"longstanding":[383],"goal":[384],"cancer":[386,404],"therapeutics,":[387],"clinical":[389],"trials":[390],"have":[391,436],"failed":[392],"due":[393],"off":[395],"effects.":[397],"High":[398],"restricted":[402],"making":[406],"it":[407],"more":[409],"therapeutically":[410],"appropriate":[411],"target.":[412],"support":[415],"development":[416],"chemotherapy":[424],"convert":[426],"chondrosarcoma":[427,465],"chemosensitive":[430],"tumor,":[431],"approach":[434],"may":[435],"applicability":[437],"other":[439],"expressing":[441],"cancers.":[442],"Citation":[443],"Format:":[444],"Keisuke":[445],"Oyama,":[446],"Max":[447],"Petersen,":[448],"Adinai":[449],"Chonweerawong,":[450],"Mark":[451],"Olsen,":[452],"Richard":[453],"M.":[454],"Terek.":[455],"blockade":[459],"abrogates":[460],"[abstract].":[466],"In:":[467],"Proceedings":[468],"AACR":[470],"Drug":[471],"Discovery":[472],"Development":[474],"(AACR":[475],"D3)":[476],"Conference;":[477],"2026":[478],"Jul":[479],"21-24;":[480],"Boston,":[481],"MA.":[482],"Philadelphia":[483],"(PA):":[484],"AACR;":[485],"Clin":[486],"Cancer":[487],"Res":[488],"2026;32(14_Suppl):Abstract":[489],"nr":[490],"B086.":[491]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2026-07-22T00:00:00"}